Auckland District Health Board   Report issue

Government Phase 2 Phase 3
Founded: New Zealand (2001)

Organization Overview

First Clinical Trial
2006
NCT00329056
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Auckland District Health Board | Auckland District Health Board, New Zealand

Active Ingredients

Drugs in Phase 3 Trials (2)

nicotine (nicorette) (1 trial)

simvastatin (zocor) (1 trial)

Drugs in Phase 2 Trials (2)

dovitinib (1 trial)

vitamin q (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Intestinal Neoplasms (Phase 3)

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4